Utilidad del PET 18F-fluordeoxiglucosa en melanoma maligno / 18F-fluorodeoxyglucose positron emission tomography in patients with malignant melanoma

Está establecida en la literatura la utilidad de la tomografía por emisión de positrones (PET) con 18F-flúordeoxiglucosa (FDG) en la etapificación, reetapificación y seguimiento del melanoma maligno. Objetivo: Evaluar los resultados del PET FDG en melanoma maligno en nuestro centro. Material y Método: Entre febrero 2003 y julio 2004, se estudiaron 33 pacientes (edad 49±14 años, 52% sexo masculino) referidos para etapificación y reetapificación de melanoma maligno. El examen fue realizado en equipo de alta resolución Siemens Ecat Exact HR+ con dosis de 13±3 mCi de FDG y glicemias en ayunas preinyección de 96±16 mg/dL. Se adquirieron imágenes de cuerpo entero, incluyendo cabeza y extremidades inferiores. El informe se basó en el análisis visual e índice cuantitativo de captación (SUV). Se comparó con otros estudios de imágenes e histología cuando estaban disponibles y se realizó seguimiento clínico. Resultados: Nueve pacientes fueron derivados para etapificación y 24 para reetapificación. En 29 casos, la localización inicial del primario era conocida y en 4 la enfermedad se diagnosticó por la presencia de metástasis ganglionares. Respecto de la localización tumoral, 6 fueron en cabeza y cuello (2 metástasis ganglionares), 5 en coroides, 5 en tronco, 5 en extremidades superiores, 11 en extremidades inferiores y 1 en mucosa (rectal). En 13 pacientes, el PET fue positivo para presencia de actividad tumoral hipermetabólica, 7 en ubicación próxima al primario y 6 alejados de éste, correspondiendo uno de estos últimos a un segundo primario (carcinoma rectal confirmado con histología). De este grupo, en 11 pacientes se confirmó tumor: en 7 hubo confirmación histológica postcirugía y en los restantes, hubo concordancia con imágenes anatómicas y clínica (1 paciente falleció); además, el PET demostró lesiones no sospechadas por otros estudios, las que no han sido confirmadas con histología. Dos fueron falsos positivos, uno por hematoma y otro por ...

Background: The usefulness of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) for the staging and follow up of malignant melanoma, is well established. Aim: To assess the results of PET FDG in patients with malignant melanoma. Patients and Methods: Thirty three patients with malignant melanoma (aged 49 ± 14 years, 17 males), referred for staging and restaging, were studied. The tomography was performed using a Siemens Ecat Exat high resolution equipment. The dose of FDG was 13 ± 3 mCi and the blood glucose levels prior to injection were 96 ± 16 mg/dl. Whole body images, including the head and legs were acquired. The report was based on the visual analysis and standardized uptake value (SUV). Results: Nine patients were referred for staging and 24 for restaging. The location of the primary tumor was known in 29 cases and in four, the disease was diagnosed due to the presence of lymph node metastases. The tumor was located in the head and neck in six patients (including two lymph node metastases), in the choroid in five, in the trunk in five, in the superior limbs in five, in the inferior limbs in 11 and in the rectal mucosa in one. In 13 patients, PET was positive for the presence of hypermetabolic tumor activity. In seven, the location was near the primary tumor and in six, it was distant. In seven patients the presence of tumor was confirmed by surgery and in four, there was concordance between the anatomical imaging and clinical outcome. Two false positive images were detected, one hematoma and one due to the presence of lymph node inflammation. In 16 cases, PET was negative and in four it was not conclusive, all these patients do not have evidence of tumor in the clinical follow up. The primary location of the tumor was not identified in patients referred for lymph node metastases. Conclusions: FDG PET is useful for the staging and re staging of patients with malignant melanoma.

Evaluación de nódulos y masas pulmonares con PET FDG de alta resolución / 18-Fluorodeoxyglucose positron emission tomography in patients with pulmonary nodules

Introducción: El diagnóstico y etapificación de pacientes portadores de lesiones pulmonares con PET-FDG permite optimizar el manejo y seleccionar la terapia más adecuada para cada uno. Objetivo: Analizar nuestra experiencia preliminar con PET-FDG en la caracterización metabólica de nódulos o masas pulmonares, correlacionándolo con histología cuando estaba disponible y evaluando el impacto en la conducta terapéutica. Material y Método: Se analizaron 58 pacientes referidos para evaluación de nódulo o masa pulmonar (62±7 años de edad; 48% sexo masculino; 40% fumadores). Los PET se realizaron en ayunas, utilizando 13 mCi de FDG-F18, con glicemia preinyección de 101± 5 mg/dl. Se adquirieron imágenes de cuerpo entero con análisis visual de cortes coronales, sagitales y transaxiales e imágenes 3D, así como análisis cuantitativo del índice de captación estandarizada SUV. Los estudios se compararon con histología y seguimiento clínico. Resultados: En 22 pacientes (38%), las lesiones pulmonares fueron hipermetabólicas y en 64%, no hubo evidencias de actividad tumoral. En 24% de los pacientes, se encontraron además lesiones extrapulmonares no sospechadas por otras técnicas de imágenes. El rango de tamaño de los nódulos/masas pulmonares era de 0,5 a 7 cm; en el grupo de PET positivo, el tamaño era mayor a 0,8 cm. Se obtuvo histología en 16/58: en 12 de ellos, se confirmó la presencia de neoplasia (75%), correspondiendo la mayoría a adenocarcinoma. Dos pacientes fueron falsos positivos, demostrándose en uno, un schwanoma abscedado y en el otro, un hamartoma. En 2 pacientes con nódulos sin actividad hipermetabólica al PET (estudio normal), sometidos a cirugía por las características del nódulo al TC, se corroboraron lesiones benignas. En los restantes pacientes con lesiones negativas, el seguimiento clínico no ha demostrado eventos hasta la fecha. Un paciente referido por nódulo pulmonar no fue incluido en el análisis debido a que en el PET presentaba ...

Background: The diagnosis and staging of pulmonary lesions with positron emission tomography (PET) with 18fluorodeoxyglucose (FDG) helps in the selection of the optimal therapy. Aim: To analyze the usefulness of FDG PET in the characterization of pulmonary nodules. Patients and Methods: Fifty eight patients referred for the assessment of a pulmonary nodule or mass (aged 62 ± 7 years, 28 males, 40% smokers), were studied. The imaging study was perfomed in the fasting state injecting 13 mCi of 18FDG. Pre injection blood glucose was 101 ± 5 mg/dl. Whole body images were acquired with visual analysis of coronal, sagittal and trans axial slices and three dimensional images. The standardized uptake value (SUV) was also calculated. Results: Pulmonary lesions were hypermetabolic in 22 patients (38%) and in the rest, there was no evidence of tumor activity. Extrapulmonary lesions were detected in 24% of patients. The size of the nodules ranged from 0.5 to 7 cm. in diameter. Those with positive PET had lesions over 0.8 cm diameter. In 12 of 16 patients with pathological study, the presence of cancer was confirmed. Two patients had false positive images. One had an abscessed Schwanoma and the other, a hamartoma. Two patients with PET images not suspicious of tumor, were operated and the pathology confirmed the absence of cancer. In the rest of patients with a negative study, the clinical follow up has been uneventful. In one patient with multiple hypermetabolic lesions with a pattern suggestive of sarcoidosis, the diagnosis was pathologically confirmed. Conclusions: FDG PET is useful for the characterization of pulmonary lesions and nodules.

An assessment of wall motion, perfusion and glucose metabolism in recent myocardial infarction: a comparison in patients with and without revascularization.

The aim of this study was to compare the extent and severity of wall motion abnormalities, perfusion and glucose metabolism, in recent myocardial infarction in patients with and without revascularization. Forty-nine patients were studied (82% men; mean age 58 years) by using echocardiography, 201Tl single photon emission computed tomography (SPECT) rest and redistribution, and 2-[18F]fluoro-2-deoxy-D-glucose (18F-FDG) SPECT at a mean of 9.2 days (range, 1-24 days) after myocardial infarction. Twenty-seven of the 49 patients underwent revascularization while the other 22 received medical therapy before echocardiography and studies using radionuclides. A contrast angiogram was obtained for each patient. A follow-up echocardiogram at 3 months was obtained for 44 patients. Images were read blindly, using a 17 segment model, with semi-quantitative analysis. In the whole group, the extent of hypokinesia was 15%+/-14 (mean+/-SD); the extent of mild defects was determined as 5%+/-6 by using 201Tl at rest, 6%+/-9 by using 201Tl redistribution, and 4%+/-6 by using 18F-FDG (P<0.0005, echocardiogram/radionuclides). Echocardiography showed that the extent of akinesia-dyskinesia was 16%+/-18 in revascularized patients and 28%+/-18 in non-revascularized patients (P=0.017). With regard to moderate and severe defects, 201Tl rest showed 19%+/-16 and 28%+/-17, respectively (P=0.047); 201Tl redistribution 17%+/-15 and 26%+/-15, respectively (P=0.043); and 18F-FDG 17%+/-13 and 24%+/-15, respectively (NS). In echocardiography, the extent of hypokinetic segments decreased from 16%+/-15 at baseline to 10%+/-11 at 3 months (P=0.045), in revascularized patients. It is concluded that, in recent myocardial infarction, hypokinesia extent on echocardiogram is greater than mild perfusion or metabolic defect extent, reflecting stunning and so the use of radionuclide techniques appear more accurate for defining the extent of myocardial infarction. Non-revascularized patients showed a significantly greater extent of akinesia-dyskinesia and moderate-severe perfusion defects than did revascularized patients, which can be considered a result of therapy. It is suggested that 201Tl rest perfusion be used for the assessment of myocardial infarction soon after revascularization.

[Treatment of hyperthyroidism with radioiodine: effects of administered dose on complications and thyroid function]. / Tratamiento del hipertiroidismo con radioyodo: efecto de la dosis administrada sobre la función tiroidea y complicaciones asociadas.

BACKGROUND: Radio-iodine is a definite therapy for Graves disease hyperthyroidism. However, the optimal dosage is still debatable. AIM: To assess the effects of different radioiodine doses on thyroid function and complications in patients with hyperthyroidism. MATERIAL AND METHODS: A retrospective analysis of 139 patients with hyperthyroidism, treated with ratio-iodine between 1988 and 1998. Radio iodine dose used was classified as low (< 10 mCi), intermediate (10-14.9 mCi) or high (> or = 15 mCi). RESULTS: Thirty-five patients were treated with low doses, 33 with intermediate doses and 71 with high doses. There were no differences between these patients in age, disease severity, frequency of post treatment euthyroidism or complications. Patients treated with low doses had a higher frequency of persistent hyperthyroidism than patients treated with high doses (25.7 and 4.2% respectively, p < 0.001). Likewise, the frequency of subsequent hypothyroidism was 60% in patients treated with low doses and 84.5% of those with high doses, in whom it also appeared earlier. Associated complications were clinically irrelevant. In seven patients, Graves ophthalmopathy progressed after treatment, but this progression was not associated with the dose used. CONCLUSIONS: Radio iodine in high doses is useful, safe and effective for the treatment of Graves hyperthyroidism.

[SPECT tomography with F 18-fluorodeoxyglucose in a recent myocardial infarction clinical case]. / Tomografía SPECT con F18-fluorodeoxiglucosa en infarto reciente del miocardio. Caso clínico.

We report a 50-year-old woman with a recent myocardial infarction in whom a myocardial perfusion single photon emission computed tomography (SPECT) with Thallium201 was done simultaneously with a F18-fluorodeoxyglucose (FDG) SPECT to study glucose metabolism. Myocardial infarction was located in the anteroseptal and apical regions and an echocardiography, done at the second day of evolution, showed a septo-apical hypokinesia. On the tenth day, a coronary angiography showed a critical lesion of the anterior descending coronary artery and an angioplasty with stent placement was performed on the next day. On the twelfth day, a resting, redistribution 201Tl SPECT to study viability and a FDG-SPECT with a dual head high-energy collimator camera were done. Images, acquired 45 min after injection, were analyzed visually. In anterior and medial apical sectors, discordance between flux and metabolism, considered a classical mismatch, was observed. Echocardiographic hypokinesia disappeared three month after revascularization.

[Experience with laparoscopic surgery for adnexal masses at the Regional Hospital of Temuco, Chile]. / Experiencia de cirugía laparoscópica en masas anexiales en el Hospital Regional Temuco-Chile.

BACKGROUND: Laparoscopic surgery has clear advantages over open surgical procedures. In gynecology, laparoscopic surgery for adnexal masses in pre or post menopausal women has been used for several years. AIM: To report the experience with gynecologic laparoscopic surgery at the Temuco Regional Hospital. PATIENTS AND METHODS: Between 1996 and 1998, laparoscopic surgery was done in 96 patients aged 16 to 56 years and open surgery in 56 patients aged 15 to 74 years, with a clinical or ultrasound diagnosis of adnexal masses or ovarian dermoid cysts. RESULTS: The most frequent tumors excised were epithelial and germinal cell. Laparoscopic surgery required a mean operative time of 69.9 min and it had a 3.1% of complications. Women subjected to this type of surgery had a mean hospital stay of 3.1 days and the mean postoperative stay was 2 days. Open surgery required an operative time of 69 min and it had no postoperative complications. The mean hospital stay for women subjected to this type of procedure was 9.5 days. CONCLUSIONS: Women subjected to laparoscopic surgical procedures for adnexal masses had a shorter hospital stay than women subjected to open surgical procedures.

[Plasma estradiol levels and duration of lactation amenorrhea]. / Niveles de estradiol plasmático y duración de la amenorrea de lactancia.

In Temuco, Chile, 114 women in fully nursing, were studied, according to their length of lactational amenorrhea and their relation with estradiol levels at 3th postpartum month. Sixty six (58%) recovery their menses before the 6th postpartum month. The length of lactational amenorrhea was 100.7-5.2 and 277 +/- 10.6 days, for those mothers who were with menses and amenorrhea, respectively. The estradiol levels were 88 pmol/l higher in the woman with short length of lactational amenorrhea. This study corroborate, that short length of lactational amenorrhea is a condition highly frequent in Chilean population. The difference in the estradiol levels may be a indicators of the early recovery of the postpartum fertility.

[Advanced endometriosis treatment with leuprolide acetate]. / Tratamiento de endometriosis avanzada con acetato de leuprolide.

Endometriosis is a disease observed in women in fertile age, it causes pelvic pain characterized by dysmenorrea and dyspareunia. Moreover, there is an association with infertility. Between the alternative of the medical therapeutics of endometriosis drugs with hipogonadotrofic and hypoestrogenic effects, as the danazol and gestrinona has been used. At present, there are analogies of GnRH factor where leuprolide acetate allow a continue liberation in a monthly administration. This is a case of a woman with extensive endometriosis that has hepatitis due to danazol and subsequently was treated with leuprolide acetate. The effectiveness of leuprolide acetate is analyzed in relation with the relief of pain and the laparoscopic evaluation of the endometriosis focus.

[General and ethnic factors associated with the duration of lactation amenorrhea]. / Factores generales y étnicos asociados a la duración de la amenorrea de lactancia.

114 women in fully nursing, were studied, according to the length of lactational amenorrhea and their relation with general characteristics and ethnic group. Of the 114 mothers, 66 (58%) recovery their menses before the 6th postpartum month. The length of lactation was 100.7 +/- 5.2 and 277.9 +/- 10.5 days, for those mothers who were with menses and amenorrhea until the 6th postpartum month, respectively. A group of Mapuche women had a higher length of lactational amenorrhea and we found differences in the frequency of suckling episodes at night. This study corroborate, that short length of lactational amenorrhea is a condition highly frequent in Chilean population and it does not have a relation the nursing pattern in general population. However, the difference in the length of lactational amenorrhea in specific ethnic group, can include some general or behavioral factors of breast-feeding.

[Influence of basal and post-feeding prolactin levels on amenorrhea during breast feeding]. / Influencia de los niveles de prolactina basal y postsucción en la amenorrea de lactancia.

Forty five women, with exclusive breastfeeding were studied, (the objective was) to explore the relationship between: basal plasma prolactin (PRL) levels and post-suckling with the duration of postpartum amenorrhea. Blood samples for measurements of PRL were taken at the third month postpartum, before an episode of suckling and 30 minutes after the suckling was initiated. The average level of basal PRL was 1,033 +/- 113 mIU/L (mean +/- SE). Women who presented long periods of amenorrhea, had an increase of the basal PRL in 632 mIU/L (X), compare to those women who had their menses before 180 days postpartum (p = 0.036) women with longer amenorrhea (p = 0.06). However there were no relationship between the menses at the sixth month postpartum and the increase of post-suckling PRL (delta PRL). In this study it was found that the levels of basal PRL had correlation with the duration of the amenorrhea, in women with exclusive breastfeeding.